Related Experiment Video
Updated: Jan 19, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Comparison of Gene Expression Responses in the Small Intestine of Mice Following Exposure to 3 Carcinogens Using the
Grace A Chappell1, Julia E Rager2, Jeffrey Wolf3
1ToxStrategies, Inc, Asheville, NC, USA.
Abstract:
Carcinogenesis of the small intestine is rare in humans and rodents. Oral exposure to hexavalent chromium (Cr(VI)) and the fungicides captan and folpet induce intestinal carcinogenesis in mice. Previously (Toxicol Pathol. 330:48-52), we showed that B6C3F1 mice exposed to carcinogenic concentrations of Cr(VI), captan, or folpet for 28 days exhibited similar histopathological responses including villus enterocyte cytotoxicity and regenerative crypt epithelial hyperplasia. Herein, we analyze transcriptomic responses from formalin-fixed, paraffin-embedded duodenal sections from the aforementioned study. TempO-Seq technology and the S1500+ gene set were used to analyze transcription responses. Transcriptional responses were similar between all 3 agents; gene-level comparison identified 126/546 (23%) differentially expressed genes altered in the same direction, with a total of 25 upregulated pathways. These changes were related to cellular metabolism, stress, inflammatory/immune cell response, and cell proliferation, including upregulation in hypoxia inducible factor 1 (HIF-1) and activator protein 1 (AP1) signaling pathways, which have also been shown to be related to intestinal injury and angiogenesis/carcinogenesis. The similar molecular-, cellular-, and tissue-level changes induced by these 3 carcinogens can be informative for the development of an adverse outcome pathway for intestinal cancer.
Insights
Hexavalent chromium (Cr(VI)), captan, and folpet induce similar molecular and cellular changes in mouse intestines, suggesting a shared pathway for intestinal carcinogenesis. These findings aid in developing adverse outcome pathways for intestinal cancer.
Area of Science:
- Toxicology
- Molecular Biology
- Carcinogenesis
Background:
- Small intestine carcinogenesis is rare in humans and rodents.
- Hexavalent chromium (Cr(VI)), captan, and folpet are known to induce intestinal carcinogenesis in mice.
- Previous studies showed similar histopathological responses in mice exposed to these agents.
Purpose of the Study:
- To analyze the transcriptomic responses to Cr(VI), captan, and folpet exposure in mouse duodenum.
- To identify common molecular mechanisms underlying intestinal carcinogenesis induced by these agents.
- To inform the development of an adverse outcome pathway for intestinal cancer.
Main Methods:
- TempO-Seq technology was used to analyze transcriptomic responses.
- Formalin-fixed, paraffin-embedded duodenal sections from mice exposed to Cr(VI), captan, or folpet were analyzed.
- Gene expression data was compared to identify differentially expressed genes and pathways.
Main Results:
- Transcriptional responses were similar across all three agents.
- 126/546 (23%) differentially expressed genes were altered in the same direction.
- 25 pathways were upregulated, including those related to cellular metabolism, stress, inflammation, cell proliferation, hypoxia-inducible factor 1 (HIF-1), and activator protein 1 (AP1) signaling.
Conclusions:
- Cr(VI), captan, and folpet induce similar molecular, cellular, and tissue-level changes in the mouse duodenum.
- The identified molecular changes are linked to intestinal injury, angiogenesis, and carcinogenesis.
- These findings support the development of a shared adverse outcome pathway for intestinal cancer.
More Related Videos
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019